{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:14:45Z","timestamp":1794665685334,"version":"4.9.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004789","name":"Oxford University | John Fell Fund, University of Oxford","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>QRISK algorithms use data from millions of people to help clinicians identify individuals at high risk of cardiovascular disease (CVD). Here, we derive and externally validate a new algorithm, which we have named QR4, that incorporates novel risk factors to estimate 10-year CVD risk separately for men and women. Health data from 9.98 million and 6.79 million adults from the United Kingdom were used for derivation and validation of the algorithm, respectively. Cause-specific Cox models were used to develop models to predict CVD risk, and the performance of QR4 was compared with version 3 of QRISK, Systematic Coronary Risk Evaluation 2 (SCORE2) and atherosclerotic cardiovascular disease (ASCVD) risk scores. We identified seven novel risk factors in models for both men and women (brain cancer, lung cancer, Down syndrome, blood cancer, chronic obstructive pulmonary disease, oral cancer and learning disability) and two additional novel risk factors in women (pre-eclampsia and postnatal depression). On external validation, QR4 had a higher C\u2009statistic than QRISK3 in both women (0.835 (95% confidence interval (CI), 0.833\u20130.837) and 0.831 (95% CI, 0.829\u20130.832) for QR4 and QRISK3, respectively) and men (0.814 (95% CI, 0.812\u20130.816) and 0.812 (95% CI, 0.810\u20130.814) for QR4 and QRISK3, respectively). QR4 was also more accurate than the ASCVD and SCORE2 risk scores in both men and women. The QR4 risk score identifies new risk groups and provides superior CVD risk prediction in the United Kingdom compared with other international scoring systems for CVD risk.<\/jats:p>","DOI":"10.1038\/s41591-024-02905-y","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T10:19:29Z","timestamp":1713435569000},"page":"1440-1447","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":144,"title":["Development and validation of a new algorithm for improved cardiovascular risk prediction"],"prefix":"10.1038","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2479-7283","authenticated-orcid":false,"given":"Julia","family":"Hippisley-Cox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A. C.","family":"Coupland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Bafadhel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E. K.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7022-3056","authenticated-orcid":false,"given":"Aziz","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0641-7341","authenticated-orcid":false,"given":"Peter","family":"Brindle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1043-4342","authenticated-orcid":false,"given":"Keith M.","family":"Channon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,18]]},"reference":[{"key":"2905_CR1","unstructured":"Cardiovascular diseases (CVDs). World Health Organization www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds) (2021)."},{"key":"2905_CR2","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1016\/j.jacc.2020.11.021","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth, G. A., Mensah, G. A. & Fuster, V. The global burden of cardiovascular diseases and risks: a compass for global action. J. Am. Coll. Cardiol. 76, 2980\u20132981 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"2905_CR3","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","volume":"63","author":"DC Goff Jr","year":"2014","unstructured":"Goff, D. C. Jr et al. 2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 63, 2935\u20132959 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"2905_CR4","unstructured":"SCORE2 Working Group & ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur. Heart J. 42, 2439\u20132454 (2021)."},{"key":"2905_CR5","unstructured":"NICE Guideline [NG238]. Cardiovascular Disease: Risk Assessment and Reduction, Including Lipid Modification (National Institute for Clinical Excellence, 2023); www.nice.org.uk\/guidance\/ng238"},{"key":"2905_CR6","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jacc.2014.06.1186","volume":"64","author":"KN Karmali","year":"2014","unstructured":"Karmali, K. N., Goff, D. C. Jr, Ning, H. & Lloyd-Jones, D. M. A systematic examination of the 2013 ACC\/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease. J. Am. Coll. Cardiol. 64, 959\u2013968 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"2905_CR7","doi-asserted-by":"crossref","unstructured":"SCORE2-OP working group and ESC Cardiovascular risk collaboration. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions. Eur. Heart J. 42, 2455\u20132467 (2021).","DOI":"10.1093\/eurheartj\/ehab312"},{"key":"2905_CR8","doi-asserted-by":"publisher","first-page":"j2099","DOI":"10.1136\/bmj.j2099","volume":"357","author":"J Hippisley-Cox","year":"2017","unstructured":"Hippisley-Cox, J., Coupland, C. & Brindle, P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ 357, j2099 (2017).","journal-title":"BMJ"},{"key":"2905_CR9","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1378\/chest.128.4.2068","volume":"128","author":"S Sidney","year":"2005","unstructured":"Sidney, S. et al. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 128, 2068\u20132075 (2005).","journal-title":"Chest"},{"key":"2905_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-02747-4","volume":"21","author":"H Wang","year":"2023","unstructured":"Wang, H. et al. Association of intellectual disability with overall and type-specific cardiovascular diseases: a population-based cohort study in Denmark. BMC Med. 21, 41 (2023).","journal-title":"BMC Med."},{"key":"2905_CR11","doi-asserted-by":"publisher","first-page":"e0137093","DOI":"10.1371\/journal.pone.0137093","volume":"10","author":"CG Sobey","year":"2015","unstructured":"Sobey, C. G. et al. Risk of major cardiovascular events in people with Down syndrome. PLoS ONE 10, e0137093 (2015).","journal-title":"PLoS ONE"},{"key":"2905_CR12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1161\/CIRCULATIONAHA.122.059706","volume":"147","author":"K Dimopoulos","year":"2023","unstructured":"Dimopoulos, K. et al. Cardiovascular complications of Down syndrome: scoping review and expert consensus. Circulation 147, 425\u2013441 (2023).","journal-title":"Circulation"},{"key":"2905_CR13","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.3399\/BJGP.2022.0088","volume":"73","author":"H Strongman","year":"2022","unstructured":"Strongman, H. et al. Cancer history as a predictor in cardiovascular risk scores: a primary care cohort study. Br. J. Gen. Pract. 73, e34\u2013e42 (2022).","journal-title":"Br. J. Gen. Pract."},{"key":"2905_CR14","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1161\/CIR.0000000000001000","volume":"144","author":"LS Mehta","year":"2021","unstructured":"Mehta, L. S. et al. Call to action: maternal health and saving mothers: a policy statement from the American Heart Association. Circulation 144, e251\u2013e269 (2021).","journal-title":"Circulation"},{"key":"2905_CR15","doi-asserted-by":"publisher","first-page":"266","DOI":"10.7326\/M14-1281","volume":"162","author":"AP DeFilippis","year":"2015","unstructured":"DeFilippis, A. P. et al. An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort. Ann. Intern. Med. 162, 266\u2013275 (2015).","journal-title":"Ann. Intern. Med."},{"key":"2905_CR16","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/sim.4780091109","volume":"9","author":"JC Van Houwelingen","year":"1990","unstructured":"Van Houwelingen, J. C. & Le Cessie, S. Predictive value of statistical models. Stat. Med. 9, 1303\u20131325 (1990).","journal-title":"Stat. Med."},{"key":"2905_CR17","first-page":"425","volume":"14","author":"PE Puddu","year":"2017","unstructured":"Puddu, P. E., Amaduzzi, P. L. & Ricci, B. Coronary heart disease incidence and competing risks: an important issue. J. Geriatr. Cardiol. 14, 425\u2013429 (2017).","journal-title":"J. Geriatr. Cardiol."},{"key":"2905_CR18","unstructured":"Facts and information about blood cancer. Blood cancer UK http:\/\/bloodcancer.org.uk\/news\/blood-cancer-facts (2022)."},{"key":"2905_CR19","unstructured":"Survival for mouth and oropharyngeal cancer. Cancer Research UK www.cancerresearchuk.org\/about-cancer\/mouth-cancer\/survival (2023)."},{"key":"2905_CR20","unstructured":"Chronic obstructive pulmonary disease (COPD). World Health Organization www.who.int\/news-room\/fact-sheets\/detail\/chronic-obstructive-pulmonary-disease-(copd) (2023)."},{"key":"2905_CR21","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1378\/chest.119.6.1691","volume":"119","author":"KR Chapman","year":"2001","unstructured":"Chapman, K. R., Tashkin, D. P. & Pye, D. J. Gender bias in the diagnosis of COPD. Chest 119, 1691\u20131695 (2001).","journal-title":"Chest"},{"key":"2905_CR22","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.chest.2016.10.031","volume":"151","author":"CR Jenkins","year":"2017","unstructured":"Jenkins, C. R. et al. Improving the management of COPD in women. Chest 151, 686\u2013696 (2017).","journal-title":"Chest"},{"key":"2905_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa1916046","volume":"383","author":"KF Rabe","year":"2020","unstructured":"Rabe, K. F. et al. Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD. N. Engl. J. Med. 383, 35\u201348 (2020).","journal-title":"N. Engl. J. Med."},{"key":"2905_CR24","unstructured":"Global strategy for prevention, diagnosis and management of COPD: 2023 report (Global Initiative for Chronic Obstructive Lung Disease, 2023); https:\/\/goldcopd.org\/2023-gold-report-2\/"},{"key":"2905_CR25","doi-asserted-by":"publisher","first-page":"e072112","DOI":"10.1136\/bmj-2022-072112","volume":"380","author":"C Crump","year":"2023","unstructured":"Crump, C. et al. Adverse pregnancy outcomes and long term risk of ischemic heart disease in mothers: national cohort and co-sibling study. BMJ 380, e072112 (2023).","journal-title":"BMJ"},{"key":"2905_CR26","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMra2109523","volume":"386","author":"LA Magee","year":"2022","unstructured":"Magee, L. A., Nicolaides, K. H. & von Dadelszen, P. Preeclampsia. N. Engl. J. Med. 386, 1817\u20131832 (2022).","journal-title":"N. Engl. J. Med."},{"key":"2905_CR27","first-page":"5","volume":"21","author":"A Majeed","year":"2004","unstructured":"Majeed, A. Sources, uses, strengths and limitations of data collected in primary care in England. Health Stat. Q. 21, 5\u201314 (2004).","journal-title":"Health Stat. Q."},{"key":"2905_CR28","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1001\/jama.2015.11082","volume":"314","author":"MJ Pencina","year":"2015","unstructured":"Pencina, M. J. & D\u2019Agostino, R. B. Sr Evaluating discrimination of risk prediction models: the C statistic. JAMA 314, 1063\u20131064 (2015).","journal-title":"JAMA"},{"key":"2905_CR29","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1177\/09622802221102623","volume":"31","author":"EF Bonneville","year":"2022","unstructured":"Bonneville, E. F., Resche-Rigon, M., Schetelig, J., Putter, H. & de Wreede, L. C. Multiple imputation for cause-specific Cox models: assessing methods for estimation and prediction. Stat. Methods Med. Res. 31, 1860\u20131880 (2022).","journal-title":"Stat. Methods Med. Res."},{"key":"2905_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1017\/S0047279400020341","volume":"16","author":"P Townsend","year":"1987","unstructured":"Townsend, P. Deprivation. J. Soc. Policy 16, 125\u2013146 (1987).","journal-title":"J. Soc. Policy"},{"key":"2905_CR31","unstructured":"Hippisley-Cox, J. Open Code Lists 2023 (QResearch, 2023); www.qresearch.org\/data\/qcode-group-library"},{"key":"2905_CR32","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1056\/NEJMoa1800256","volume":"379","author":"A Rawshani","year":"2018","unstructured":"Rawshani, A. et al. Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 379, 633\u2013644 (2018).","journal-title":"N. Engl. J. Med."},{"key":"2905_CR33","doi-asserted-by":"crossref","unstructured":"Wolbers, M., Koller, M. T., Witteman, J. C. M. & Steyerberg, E. W. Prognostic models with competing risks: methods and application to coronary risk prediction. Epidemiology 20, 555\u2013561 (2009).","DOI":"10.1097\/EDE.0b013e3181a39056"},{"key":"2905_CR34","doi-asserted-by":"crossref","unstructured":"Kalbfleisch, J. D. & Prentice, R. L. The Statistical Analysis of Failure Time Data (John Wiley & Sons, Inc., 2002).","DOI":"10.1002\/9781118032985"},{"key":"2905_CR35","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/ije\/28.5.964","volume":"28","author":"P Royston","year":"1999","unstructured":"Royston, P., Ambler, G. & Sauerbrei, W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int. J. Epidemiol. 28, 964\u2013974 (1999).","journal-title":"Int. J. Epidemiol."},{"key":"2905_CR36","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1002\/sim.3618","volume":"28","author":"IR White","year":"2009","unstructured":"White, I. R. & Royston, P. Imputing missing covariate values for the Cox model. Stat. Med. 28, 1982\u20131998 (2009).","journal-title":"Stat. Med."},{"key":"2905_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/9780470316696","volume-title":"Multiple Imputation for Nonresponse in Surveys","author":"DB Rubin","year":"1987","unstructured":"Rubin, D. B. Multiple Imputation for Nonresponse in Surveys (John Wiley & Sons, 1987)."},{"key":"2905_CR38","doi-asserted-by":"publisher","first-page":"e069249","DOI":"10.1136\/bmj-2021-069249","volume":"377","author":"N van Geloven","year":"2022","unstructured":"van Geloven, N. et al. Validation of prediction models in the presence of competing risks: a guide through modern methods. BMJ 377, e069249 (2022).","journal-title":"BMJ"},{"key":"2905_CR39","unstructured":"Linden A. ASCVD: Stata Module for Computing ACC\/AHA 10-Year Risk for an Initial Hard Atherosclerotic Cardiovascular Disease (ASCVD) Event. Statistical Software Components S459162 (Boston College Department of Economics, 2023)."},{"key":"2905_CR40","doi-asserted-by":"crossref","unstructured":"SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration. SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe. Eur. Heart J. 44, 2544\u20132556 (2023).","DOI":"10.1093\/eurheartj\/ehad260"},{"key":"2905_CR41","unstructured":"Stata file to calculate score2 risk. University of Cambridge Cardiovascular Epidemiology Unit https:\/\/www.phpc.cam.ac.uk (2023)."},{"key":"2905_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6947-8-53","volume":"8","author":"AJ Vickers","year":"2008","unstructured":"Vickers, A. J., Cronin, A. M., Elkin, E. B. & Gonen, M. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med. Inf. Decis. Mak. 8, 53 (2008).","journal-title":"BMC Med. Inf. Decis. Mak."},{"key":"2905_CR43","doi-asserted-by":"publisher","first-page":"i6","DOI":"10.1136\/bmj.i6","volume":"352","author":"AJ Vickers","year":"2016","unstructured":"Vickers, A. J., Van Calster, B. & Steyerberg, E. W. Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests. BMJ 352, i6 (2016).","journal-title":"BMJ"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-024-02905-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-024-02905-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-024-02905-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T16:16:20Z","timestamp":1716308180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-024-02905-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,18]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["2905"],"URL":"https:\/\/doi.org\/10.1038\/s41591-024-02905-y","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,18]]},"assertion":[{"value":"21 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors have completed the International Committee of Medical Journal Editors uniform disclosure form at . J.H.-C. reports grants from the National Institute for Health Research, John Fell Oxford University Press Research Fund, Cancer Research UK (C5255\/A18085), Wellcome Institutional Strategic Support Fund (204826\/Z\/16\/Z) and other research councils during the conduct of the study. J.H.-C. is an unpaid director of QResearch, a not-for-profit organization that is a partnership between the University of Oxford and EMIS Health, which supplied the QResearch database used in this work. Until 9 August 2023, J.H.-C. had a 50% shareholding in ClinRisk and co-owned it with her husband, who was an executive director. On 9 August 2023, 100% of the share capital was donated to Endeavour Health Care Charitable Trust, and the company was renamed Endeavour Predict. J.H.-C. is an unpaid consultant to Endeavour Predict, and her husband is a nonexecutive director to cover the transition. The company licenses software both to the private sector and to NHS bodies or bodies that provide services to the NHS (through GP electronic health records providers, pharmacies, hospital providers and other NHS providers). This software implements algorithms (including QRISK3) that were developed from the QResearch database during her time at the University of Nottingham. C.A.C.C. reports receiving personal fees from ClinRisk outside of this work. K.M.C. reports grant funding from the British Heart Foundation and is an academic cofounder, shareholder and the director of Caristo Diagnostics, a University of Oxford cardiac image analysis spin-out company. M.B. received grants paid to her institution from AstraZeneca, Roche, Asthma + Lung UK and Horizon Europe, consulting fees or honoraria paid to her institution from AstraZeneca, Sanofi, GSK and Areteia, and support from Chiesi for attending meetings.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}